Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Ernexa Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ERNA | Benzinga

Q: What sector and industry does Ernexa Therapeutics (ERNA) operate in?

Ernexa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Ernexa Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ERNA.

Open	$2.26
Close	-
Volume / Avg.	103.71K / 26.82K
Day Range	$2.08 - $2.35
52 Wk Range	2.14 - 39.38
Market Cap	$9.48M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	3.41%
Days to Cover	1

Recent News

Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics

Lineage Cell Therapeutics Inc (NYSE: LCTX) has initiated certain development activities to generate a novel hypoimmune induced pluripotent stem cell (iPSC) line under the company’s exclusive option and license agreement with Eterna Therapeutics Inc (NASDAQ:

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$2.26
Close	-
Volume / Avg.	103.71K / 26.82K
Day Range	$2.08 - $2.35
52 Wk Range	2.14 - 39.38
Market Cap	$9.48M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	3.41%
Days to Cover	1

About Ernexa Therapeutics Inc.

Sector

Health Care

Industry

Biotechnology

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medici...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ernexa Therapeutics (ERNA) stock?

You can purchase shares of Ernexa Therapeutics (NASDAQ:ERNA) through any online brokerage.

View our list of the best stock brokerages

Who are Ernexa Therapeutics (ERNA) competitors?

Other companies in Ernexa Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Sensei Biotherapeutics (NASDAQ:SNSE) and GlycoMimetics (NASDAQ:GLYC).

What is the forecast, or price target, for Ernexa Therapeutics (ERNA) stock?

There is no analysis for Ernexa Therapeutics to provide a consensus price target.

What is the current price for Ernexa Therapeutics (ERNA)?

The stock price for Ernexa Therapeutics (NASDAQ: ERNA) is $2.28 last updated June 13, 2025 at 3:18 PM EDT.

Does Ernexa Therapeutics (ERNA) pay a dividend?

There are no upcoming dividends for Ernexa Therapeutics.

When is Ernexa Therapeutics (NASDAQ:ERNA) reporting earnings?

Ernexa Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is Ernexa Therapeutics (ERNA) going to split?

There is no upcoming split for Ernexa Therapeutics.

What sector and industry does Ernexa Therapeutics (ERNA) operate in?

Ernexa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Ernexa Therapeutics Stock Price, Quotes and Forecasts

Ernexa Therapeutics (ERNA) Forecast